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Abstract: Nutrition is crucial for the management of patients affected by chronic kidney disease
(CKD) to slow down disease progression and to correct symptoms. The mainstay of the nutritional
approach to renal patients is protein restriction coupled with adequate energy supply to prevent
malnutrition. However, other aspects of renal diets, including fiber content, can be beneficial. This
paper summarizes the latest literature on the role of different types of dietary fiber in CKD, with special
attention to gut microbiota and the potential protective role of renal diets. Fibers have been identified
based on aqueous solubility, but other features, such as viscosity, fermentability, and bulking effect in
the colon should be considered. A proper amount of fiber should be recommended not only in the
general population but also in CKD patients, to achieve an adequate composition and metabolism of
gut microbiota and to reduce the risks connected with obesity, diabetes, and dyslipidemia.
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1. Introduction
Chronic kidney disease (CKD) is a growing public health problem, affecting about 10% of the
population worldwide, with diabetes, hypertension, and obesity the most important risk factors for
its occurrence in developed countries [1]. The importance of nutrition in a nephrology setting has
been recognized as crucial for the management of CKD to slow down disease progression and to
correct symptoms. The mainstay of dietary treatment of renal patients has been protein restriction
coupled with adequate energy supply to prevent malnutrition and with the correct management of
electrolytes abnormalities [2]. Besides, renal diet composition may also influence gut microbiota, which
has been proved to play a role in reducing toxins production and preserve renal function, slowing
CKD progression [3–6]. Several aspects of renal diets, including fiber content, can modulate the gut
microbiota metabolism of CKD patients [7]. Nutritional counseling can help individuals limit dietary
phosphorus and potassium load while maintaining or increasing dietary fiber intake [8,9].
This paper aimed to summarize the latest literature on the role of different types of dietary fiber in
CKD, with special attention to gut microbiota and the potential protective role of renal diets.
2. Fiber Definition and Recommendation
The research about the use of dietary fiber and human health is large and heterogeneous. Since the
1970s in Western countries, recommendations of scientific societies [10–13] for the general population
have suggested an adequate intake of fiber for a healthy diet (Table 1). The nutrition nephrology
guidelines KDOQI (Kidney Disease Outcomes Quality Initiative) [14], KDIGO (Kidney Disease
Improving Global Outcomes) [15], and EBPG (European Best Practice Guidelines) [16] do not provide
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specific guidance for CKD patients. Beto et al. [17] indicated, for all CKD stages, the same amount
suggested for the general population.
Table 1. Guidelines recommendations on fiber intake in the general population. No specific
recommendation is provided for CKD (chronic kidney disease) patients by the available nephrology
guidelines.
• ADA (2014): 14 g/1000 kcal or 25 g/day women, 38 g/day men [10]
• AHA (2014): Rich in fiber [11]
• USA Guideline (2015): 14 g/1000 kcal [12]
• EFSA European Guideline (2010): 25 g/day [13]
Legend: ADA = American Dietetic Association; AHA = American Heart Association; EFSA= European Food
Safety Authority.
In the general population, the current guidelines recommend a total fiber (both soluble and
insoluble) intake of 20–35 g/day [10]. The mean intake of dietary fiber in the United States is 17 g/day
with only 5% of the population meeting the adequate intake [18].
Regulatory Authorities recommend a proper fiber intake to assess benefits on stool excretion
for laxation and a regular intestinal transit, as well as for its metabolic action in maintaining proper
cholesterol and glucose metabolism [19]. The role of fiber in health and disease is more complex,
and the modern analytic techniques open the way to the complex interaction on human metabolism
connected with the fiber intake. Beyond the total quantity of fiber to be consumed, no indications
are specifying the types of fiber or the proportions of the different fiber-containing food to reach an
optimal intake.
An appropriate definition of dietary fiber is essential [20]. In 2007, FAO/WHO experts underscored
that the term dietary fiber is referred to as nondigestible carbohydrates contained in grains, seeds,
vegetable, and fruits [21]. This is the most internationally accepted definition. The US Codex
Alimentarius Commission [22], which sets international guidance standards for food, introduced
the following definition of dietary fiber in 2009: carbohydrate (CHO) polymers with ten or more
monomeric units, which are not hydrolyzed by the endogenous enzymes in the small intestine of
humans and belong to the following categories: (a) edible CHO polymers, naturally occurring in the
food as consumed; (b) CHO polymers, obtained from food raw material by physical, enzymatic, or
chemical means; and (c) synthetic CHO polymers [22]. It was also indicated that individual countries
could decide whether they accept oligosaccharides with a degree of polymerization (DP) from three to
nine (included) as being fiber, raising some uncertainty regarding a correct and univocal definition.
Dietary fiber is made up of carbohydrates polymers with three or more monomeric units (MU),
plus associated substances. Table 2 presents the classification of dietary fiber according to chemical
structure. Other physicochemical characteristics like water solubility, viscosity, and fermentability
have been considered [23].
In the European Union (EU), the minimum number of carbohydrates in fibers is three (MU ≥ 3).
To be included in the fiber definition, a health benefit is required, such as “decrease of intestinal
transit time, an increase of stool bulk”, “reduction in blood cholesterol”, and “modulation of glucose
metabolism” [24]. The adequate intake for the US was based on the cholesterol-lowering effect. The
European Food Safety Authority (EFSA) indications on health claims related to dietary fiber report
the use of the term “soluble” and “insoluble” in the literature to classify dietary fiber according to
a physicochemical characteristic linked to different physiological effects [25]. However, aqueous
solubility does not always predict physiological effects, so a different classification according to the
main characteristic of viscosity, fermentability, and bulking effect in the colon, which is related to water
solubility and swelling capacity, has been proposed [23]. There is an overlap between the characteristics
used for classification, creating confusion in correlating specific dietary fiber characteristics to observe
health outcomes (Table 3).
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Table 2. Classification of dietary fiber according to main chemical components, main food sources, and
intrinsic characteristics (data derived from Stephen et al. [23]).
Subgroup Class of Poly, Oligosaccharides Main Sources WaterSolubility Viscosity Fermentability
No Starch
Polysaccharides,
MU ≥ 10
Cellulose Outer layers of cereals. - - +
Hemicellulose
Starchy endosperm and outer layers
of cereals, fruits, and vegetable cell
walls.
-
(soluble
after
alkaline
extraction)
- -
Seed (psyllium). ++ +++ +
Cereal grains (β-glucans) + ++ ++
Mannans Seeds, green coffee beans, aloe vera. + - ++
Heteromannans
Grain legumes, guar gum
(galactomannans), Konjac
(glucomannans).
+++ +++ ++
Pectins Fruit peel, beetroot, rice endosperm,legumes. ++ ++ ++
Inulin and fructans Chicory root, Jerusalem artichoke,onion, cereal grains (2–3% w/w). ++ - ++
Resistant
oligosaccharides,
MU 3-9
α-galactosides
Polymers derived by hydrolysis from
polysaccharides. +++
- +++
β fructooligosaccharides (FOS)
α-galactooligosaccharides (GOS)
β-galactooligosaccharides (TOS)
Xylo-oligosaccharides (XOS)
Arabino-xylooligosaccharides
(AXOS)
Polydextrose
Resistant starch,
MU ≥ 10
Type 1 - physically inaccessible
starch Type1- whole grains and legumes - ++
Type 2 - granular starches Type 2- Green banana ++
Type 3 - gelatinized and
retrograded starch
Type 3- Cooled starches in cooked
starchy food ++
Type 4 - chemically modified Type 4- synthetized +
Associated
substances Lignin, waxes, chitins Cell walls of plants, red algae, fungi. - waxes ++ -
MU = monomeric
units
Solubility refers to dissolution in water, but it is the viscosity (capacity to gel with water) of
certain soluble fibers that influences chyme consistency and slows enzymatic digestion of consumed
nutrients to absorbable components. Oligosaccharides are highly soluble, and fermentable fibers
include fructooligosaccharides (FOS) and galactooligosaccharides (GOS). These short-chain fibers are
highly fermentable due to their small size and solubility.
Soluble, non-viscous, readily fermentable fibers (inulin, wheat dextrin) dissolve in water and
are rapidly and completely fermented [26]. Soluble, viscous, readily fermentable fibers (β-glucan,
gums, pectin) are similar but form a gel-like consistency with water [27]. These characteristics are then
lost following fermentation. Soluble, viscous, slowly fermented fibers (psyllium) also form a gel-like
consistency but do not undergo extensive fermentation. As such, the capacity to interact with water is
preserved throughout the colon. This allows softening of stools in those suffering from constipation
and adds firmness to loose stools. Insoluble fibers (wheat bran, lignin, cellulose) exert a laxative effect
by stimulation and irritation of gut mucosa to increase secretion and peristalsis [28].
EFSA included in the definition of dietary fiber also polymers obtained by physical, enzymatic,
or chemical means with a demonstrated beneficial physiological effect [25]. The EU Regulation (EC)
No. 1924/2006 on nutrition and health claims for foods specifies the requirement for the use of the
terms “source of fiber” or “high in fiber”. The claim that a food is a source of fiber may only be made if
the product contains at least 3 g of fiber per 100 g or at least 1.5 g of fiber per 100 kcal (418 kJ). The
claim that a food is high in fiber, and any claim likely to have the same meaning for the consumer, may
only be made if the product contains at least 6 g of fiber per 100 g or at least 3 g of fiber per 100 kcal
(418 kJ) [29].
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Table 3. Main fibers physicochemical characteristics (data derived from O’Grady [28]).
Water Solubility Viscosity Fermentability
YES NO YES NO YES NO
Beta-glucan, Gums, Pectins, Mucilage
Lignans
Fructo-oligosaccharides, Galacto-oligosaccharides
Inulin
Psyllium
Resistant starch, Cellulose
3. Dietary Fiber and Chronic Kidney Disease
The study of fiber and other dietary components is complex, not only for different proprieties of
different kind of fibers. First, it is difficult to assess the dietary fiber intake because no biomarkers are
available, and dietary histories are often unreliable. Then, the interaction of fiber with the individual
human gastrointestinal tract can change due to previous dietary fiber habits, gut microbiota differences
in various individuals, and previous disease or medication [30]. Fiber intake has been investigated
as a dietary aspect that may exert a favorable action on renal health through different mechanisms
(Figure 1).
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Figure 1. Potential beneficial effects of fiber in renal health. Fiber intake and fermentation are of
crucial importance in the kidney-intestine axis, both for kidney health and for outcomes associated
with other relevant conditions, such as cancer, diabetes, obesity (for references, see text). CKD: chronic
kidney disease.
3.1. Role in Intestinal Transit
The bulking effect is important to maintain a proper intestinal transit. In Europe, constipation is
one of the most common gastrointestinal complaints; the causes are variable, including medication
effects, increasing age, lifestyle, and dietary habits [31]. The bulking effect is dependent on the
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water-binding capacity of dietary fiber and on fermentation, which alters the osmotic balance and
increases fecal biomass. Fiber from wheat bran has been shown to have a high bulking effect (5.4 g
stool weight increase per 1 g of wheat fiber) due to its resistance to fermentation [18]. In a cohort study
conducted in 3 million US Veterans, a severe constipation status was correlated with an increased risk
of CKD and a faster decline of glomerular filtration rate [32]. In CKD, medications like phosphate
binders or antibiotics, water reduction, and dietary restriction due to potassium management may
exacerbate constipation [33,34]. Constipation rates reach 63% in hemodialysis patients and 29% in
peritoneal dialysis [35]. Considering that intestinal transit time is increased in advanced kidney
failure, an increase in dietary fiber should benefit CKD patients. In addition to reducing constipation,
this effect could improve the intestinal microbial profile and increase concentrations of fermentation
products [36].
3.2. Role in Weight Control
Similar viscous types of fiber (such as guar gum, pectins) are associated with reduced appetite
and better control of body weight [37]. A diet rich in fiber is characterized by the presence of whole
cereals, legumes, fruits, vegetables, and a low-density caloric amount.
Observational evidence for the effects of different sources or types of dietary fiber on body weight
management is rather limited and inconsistent in terms of strength of association. There is some
evidence from pooled data from five EPIC (European Prospective Investigation into Cancer and
Nutrition) centers study that individuals with higher total and grain fiber intakes experienced smaller
annual weight gains. Over the 6.5-years follow-up, for each 10 g greater intake of total fiber, the
mean weight gain was lower by 39 g/year in the 89,000 European participants. This small annual
improvement might potentially contribute to significantly greater lifetime weight stability in higher
fiber consumers [38]. Obesity is an important risk factor for CKD, and healthy body weight throughout
the life, as a result of education to a proper diet and lifestyle, is a public health goal and should be
recommended to prevent kidney disease [39].
A reduced appetite can be a harmful effect in patients with end-stage kidney disease when
symptoms of uremia as loss of appetite or nausea can negatively affect their nutritional status. Salmean
et al. [40] conducted a pilot study to test the impact of a diet with foods added in fiber on appetite in
adults with CKD. Participants were provided with control foods (cookies, snack bars, and breakfast
cereal) containing <2 g/day of fiber for 2 weeks, followed by similar foods providing 23 g/day (pea
hull, inulin, and resistant corn dextrin) for 4 weeks, to incorporate into their usual diets. No change in
body weight or energy intake occurred over the six-week study. Scores for appetite did not change,
but suggested poor appetite in seven participants, with or without added fiber, and a significant risk of
at least 5% weight loss within six months. Low food intake is an important risk factor for malnutrition
and adverse outcomes in patients with CKD. Poor appetite is common with progression of renal
damage, and the impact of a diet rich in fiber on appetite, with or without supplements, justifies further
investigation at a different stage of CKD [40].
3.3. Role in Cancer Prevention
Kidney cancer is among the 10th most common presenting cancers in the Western world, with
lifestyle and dietary habits likely playing a significant etiological role [41]. A recent review by Huang
et al. [42] summarized the evidence from two cohorts and five case-control studies in a meta-analysis
on dietary fiber intake and risk of renal cell carcinoma (RCC). When comparing the highest against
the lowest dietary fiber consumers, the pooled estimate of risk for renal cell carcinoma indicated
that the total dietary fiber intake was associated with reduced RCC risk (RR 0.84, 95% CI 0.74–0.96).
The study also revealed some differential associations according to the source of dietary fiber (greatest
risk reductions for fiber from legume and vegetable sources, rather than fiber from grains or fruit).
However, using a dose-response meta-analysis approach, the authors were unable to report any
evidence of diminishing risk with increasing intakes of dietary fiber. This points to the need for
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further, large prospective cohort studies to explore potential links between dietary habits and kidney
cancer [42]. The World Cancer Research Fund analysis of the evidence on cancer prevention and
survival recommends a diet rich in whole grain cereals, fruits, and vegetables [43].
3.4. Role in Glucose and Lipid Metabolism
Diabetes is a growing worldwide epidemic, and CKD is a debilitating complication. Cardiovascular
disease (CVD) is a frequent cause of mortality in patients with DM, and CKD is a risk factor for
CVD [14,15].
There is enough evidence to support several EFSA health claims that certain types of fiber,
including β-glucans and pectins (viscous, soluble, and fermentable), if consumed within a meal, may
contribute to the reduction of blood glucose rise after a meal [26]. Psyllium (viscous, soluble but not
fermentable), which delays degradation and absorption of nutrients, can reduce total glucose and
cholesterol absorption [23,44].
The cholesterol-lowering effect depends on increased viscosity of fiber, reducing the re-absorption
of bile acids, increasing the synthesis of bile acids from cholesterol, and reducing circulating
LDL-cholesterol concentrations [28].
Evidence supports a reduced risk for type 2 diabetes with additional fiber daily consumption.
Both soluble and insoluble fibers are associated with improved outcomes. The American Diabetes
Association (ADA) recommends that patients with DM should consume at least 14 g of fiber for each
1000 Kcals daily, and it suggests that carbohydrate intake from vegetables, fruits, legumes, and whole
grains, with an emphasis on foods higher in fiber and lower in glycemic load, is preferred over other
sources of carbohydrates [10]. The American Heart Association (AHA) also endorses healthy dietary
patterns rich in fiber to prevent CVD, such as Dietary Approaches to Stop Hypertension (DASH) and
Mediterranean diets [11].
A recent review analyzed the role of dietary fiber in diabetic kidney disease [45]. Starting from
1814 studies, 48 articles were evaluated, and due to lack of dietary or renal outcome information, only
seven clinical trials were included. Moreover, only two of them provide information about the kinds of
fiber used, soluble or insoluble. Renal outcomes were albuminuria, proteinuria, changes in estimated
glomerular filtration rate, dialysis. A vegetarian diet showed a beneficial effect on renal outcomes,
but the individual effect of fiber intake could not be evaluated. Limitation for the small numbers of
studies, for the short term follow-up, and for the amount of fiber, which was lower than recommended
by most guidelines, led to the conclusion that further investigation is needed to deliver evidence that is
currently still limited [45].
3.5. Role in the Gut Microbiome
Dietary fiber is the key substrate for microbial growth of bacteria living in the gut (prebiotic action).
The gut microbiota is a true ecosystem made up of an estimated number of 3.8 x 1013 microorganisms
living throughout the human body of a 70 kg individual [46]. Thus, the number of bacteria in the body
is of the same order as the number of human cells (3.0 × 1013), and their total mass is about 0.2 kg. The
colonization is established in the first years of life, reaching the maximum complexity in adulthood,
when the dominant species are Bacteroides, Firmicutes, and Actinobacteria [47].
Fermentable fibers, such as oligosaccharides, β-glucans, gums, some hemicelluloses, and some
resistant starches, are the substrate for bacteria metabolism producing short-chain fatty acids (SCFAs),
primarily acetate, propionate, and butyrate [26]. Recent evidence has supported the role of these
metabolites in the regulation of immunity, blood pressure, glucose, and lipid metabolism. These effects
may represent the link between microbiota and host homeostasis [48]. More than 90% of SCFAs are
absorbed by colonic epithelial cells, providing an important energy source [49]. Due to fermentation,
fiber provides an energy intake of 2 kcal per gram [15]. Butyrate is rapidly used as an energy source
by colonocyte; most of acetate and propionate enters the portal circulation and peripheral blood [50].
SCFAs reach the bloodstream and act on the immune system by modulating inflammatory gene
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expression, chemotaxis, differentiation, proliferation, and apoptosis [51]. These beneficial effects are
related to their property as histone acetylation inhibitors and activation of transmembrane cognate G
protein-coupled receptors [52]. An important role of fiber is the trophic action on intestinal epithelial
cells, a physical barrier against the entrance of pathogenic microorganisms or their molecules into the
portal circulation. Changes in the intestinal barrier with an increased permeability are common in CKD.
SCFAs may contribute to kidney health by reducing stimuli to systemic inflammation, maintaining an
intact mucosal barrier, both modulating the immune system and the anti-inflammatory response [51].
Data from 14,543 participants in the National Health and Nutrition Examination Survey III
(NHANES III) showed for each 10 g/day increase in total fiber intake (total, soluble, and insoluble), the
odds of elevated serum C-reactive protein levels were decreased by 11% and 38% in those without and
with kidney disease, respectively [53]. The authors concluded that taken together these data suggest
a stronger role of dietary fiber in lowering inflammation in the CKD population and this is a likely
potential mechanism for the association of higher dietary fiber with lower mortality. Unfortunately,
according to NHANES III data, the average dietary fiber intake in the CKD population was about
15.4 g/day, which was much lower than recommended [53].
3.6. Role in Biomarkers of Renal Function
A dysbiosis of the microbiota appears to be a risk susceptibility factor for the development of
kidney disease, following injury or in predisposed individuals. The progressive reduction in kidney
function significantly contributes to worsening the intestinal dysbiosis [54,55]. Therefore, the imbalance
in gut microbiota contributes to the accumulation of gut-derived uremic toxins [56]. Toxic gases,
indoxyl sulfate, p-Cresyl sulfate, amines, ammonia, and trimethylamine n-oxide (TMAO) as well as
products of bacterial lysis translocation, i.e., precursors for lipopolysaccharides (LPS), may be absorbed
into the bloodstream and be responsible for systemic inflammation. Indeed, several studies have shown
that these toxins are reliable markers of cardiovascular disease and mortality in CKD patient [47,57].
The increase in bowel transit velocity, the reduction of constipation, and changes of the intestinal
bacterial composition may reduce serum urea by altering the urea enterohepatic cycling, increasing
nitrogen excretion via fecal mass [58]. Because urea is diffusible through the colon and creatinine is
metabolized by intestinal bacteria, their net endogenous production and hence their retention can be
potentially reduced in CKD patients. This phenomenon could also represent a bias for the estimation of
residual renal function. Data about dietary fiber effects in CKD using serum creatinine and urea have
been reviewed by Chiavaroli et al. [59]. This systematic review and metanalysis identified 8051 reports,
but it included only 14 controlled feeding trials that met the eligibility criteria for analyses, involving
143 participants (median number of participants: 9, range 3–22) with a median age of 51.9 years.
Though no data were reported about the CKD stage and fiber intake at baseline, the study is relevant
because the supplemented median fiber dose, about 27 g/day, is consistent with the recommendation
for adults. Results indicate a reduction in serum urea and creatinine levels associated with dietary fiber
intake, which occurred in a dose-dependent manner for creatinine. However, it should be kept in mind
that accumulation of urea and creatinine do not directly induce renal damage. In most studies, fiber
was supplemented as fermentable fiber type (psyllium, gum Arabic, inulin, and lactulose), yielding
a total median fiber dose of 26.9 g/day, with a very high range of 3.1–50 g/day. The incidence of
CKD assessing e-GFR was evaluated by the Tehran Lipid and Glucose Study [60] that followed 1630
participants, mean age 42.8 years, for 6 years, who were initially free from CKD. Data about dietary
fiber was collected with a valid and reliable food frequency questionnaire. The authors observed a
reduced risk of incident CKD in higher tertiles of fiber intake (average 36.6 g/day). The study reported
the distribution of fiber from different foods (fruits, vegetables, cereals, and legumes). With every
5 g/day increase in total fiber, the risk of incident CKD decreased by 11%; a protective association was
observed for vegetables and legumes fiber. Odds ratios for participants in the highest compared with
the lowest tertile of fiber from vegetables was 0.63 (95% CI 0.43–0.93), and, from legumes, it was 0.68
(95% CI 0.47–0.98) [60].
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4. Renal Diets
The diets for CKD patients are characterized by the control or reduction of protein intake, the
increase of carbohydrates supply, and the increase of plant-origin protein and food with respect to
animal-origin foods. In other words, with respect to the current western diet pattern, diets implemented
in renal patients favor complex carbohydrate and fibers with respect to animal-origin proteins and
refined foods [61].
All these aspects may have several favorable effects on gut microbiota metabolism. One of the
effects of a successful dietary protein restriction is the reduced nitrogen waste products retention,
the most common biomarker being urea. In CKD, the accumulation of urea in body fluids causes
its diffusion into the intestinal lumen, where it is converted into ammonia by the urease-positive
species, and finally hydrolyzed to ammonium hydroxide [7]. The latter causes changes of the tight
junctions, damage to the epithelial barrier, and an increase in intestinal permeability, resulting in
the passage into the bloodstream circulation of bacterial toxins [62]. Consequently, the activation
of local and systemic chronic inflammatory mechanisms induces further damage to the intestinal
epithelial barrier, triggering a vicious circle that also favors the progression of renal damage [63].
Through saccharolytic fermentation in the intestinal lumen, carbohydrates are converted to SCFAs,
such as acetate, butyrate, and propionate, which have anti-inflammatory and protective effects on
immune function and intestinal barrier integrity. On the other hand, the products of proteolytic
fermentation, such as phenols, indole, amines, and ammonium, are potentially toxic metabolites
and reduce the circulating levels of SCFAs [56]. Complex carbohydrates, such as dietary fiber and
fructo-oligosaccharides (FOS), obtained by hydrolysis of plant-origin inulin, are today recognized as
prebiotics, that is substances able of favorably modifying the composition of gut microbiota, stimulating
growth, and metabolic activity of beneficial microorganisms, such as Bifidobacteria and Lactobacilli
with saccharolytic metabolism [57,64,65]. Recent data showed that serum concentrations of p-cresol
and indoxyl sulfate were reduced by oral p-inulin intake in CKD patients on hemodialysis [7].
Therefore, the diet may have a potential impact on modifying the composition of the microbiota
and optimizing homeostasis in patients with CKD. Low-protein renal diets remain crucial in the
therapy of patients with CKD [66]. Diets with a very low protein and vegan content reduce the intake
of substrates for protein fermentation and ensure a high intake of dietary fiber, which increases the
transit speed in the colon, decreasing the production and absorption of uremic toxins [2]. Patients with
CKD, not yet on dialysis, switched from a mild dietary protein restriction to a strict protein restriction
(0.3 g/kg body weight/day) with supplementation of essential amino acids, and keto-analogs (KA)
showed a reduction of 37% in the blood concentration of indoxyl sulfate, achieving at the same time
an adequate protein metabolism and a low production of urea [67]. In a retrospective, propensity
score-matched study of CKD patients who received more than 3 months of a KA supplemented
low-protein diet during the year preceding the start of dialysis, a lower long-term risk of all-cause
mortality (hazard ratio (HR) 0.77, 95% CI 0.70–0.84), major cardiac and cerebrovascular events (HR 0.86,
95% CI 0.78–0.94), and infection-related death (HR 0.76, 95% CI 0.67–0.87) were observed compared to
patients on a different non-specified diet [68]. Bellizzi et al. [69] confirmed that a very low-protein diet
supplemented with amino acids and KA during CKD does not increase mortality in the subsequent
renal replacement treatment period. Similarly, in selected (14% of screened patients) compliant patients
following a vegetarian keto-analog–supplemented very low–protein diet, which is rich in fiber, it was
shown that this kind of diet is nutritionally safe and could defer dialysis initiation [70].
Dietary interventions, consisting of the increase of complex carbohydrates and fibers intake with a
reduction of animal proteins and refined and processed foods, are potentially useful in the initial phases
of CKD to reduce uremic toxins production, which is associated with the progression of CKD [7,71].
This is the case of the Mediterranean diet or the DASH (Dietary Approaches to Stop Hypertension)
diet, characterized by a high intake of food of vegetable origin rich in natural and fiber prebiotics and
reduced salt intake, refined sugars, animal fats, and red meats [72].
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Furthermore, it is useful to limit the consumption of processed food products because modern
conservation processes, which have the purpose of eliminating pathogenic bacteria and guarantee the
durability of food, reduce the intake of even commensal microorganisms beneficial for the intestinal
flora, and because these products can constitute “hidden” sources of phosphates and sodium. Instead,
in the most advanced stages of CKD, low protein diets rich in carbohydrates, and sometimes, vegetarian
diets are useful options. Finally, it is known that physical activity is associated with benefits on blood
pressure control, glucose and lipid metabolism, and endothelial function. A sedentary lifestyle slows
intestinal transit, and preliminary evidence suggests that exercise is associated with greater changes in
gut microbiota and a reduction in pathogenic components. In the patient with CKD, exercise is an
anabolic stimulus that integrates nutritional interventions to counteract the loss of lean mass, positively
influencing nutritional status and quality of life. Therefore, in the management of CKD patients at any
stage, regular physical activity should be promoted as an integral part of the nutritional plan [73].
5. The Fiber in Renal Diets
The analysis of nutrients content of four different types of diets for renal patients showed an
average fiber amount of 7.66 g/1000 Kcal for conventional low protein diet (0.6 g protein/kg), 16 g/1000
Kcal of low-protein vegan diet (0.6 g protein/kg), 11.6 g/1000 Kcal for very low protein diet (VLPD),
and 10.4 g/1000 Kcal for a 0.8 g protein/kg diet [74].
In Italy, an animal-based low protein diet includes the use of special low protein foods, formulated
to give a high number of calories with negligible content of nitrogen, potassium, and phosphorous. In
other words, the proteins in the diet are mostly from the animal source because cereals and legumes are
excluded and substituted by high-energy protein-free products. These are starch-made substitutes of
regular bread, pasta, and bakery products, supported by a national health system, with a formulation
high in technological value that allows a similar taste to traditional products [66,75]. Fibers are already
present in special protein-free foods, baked products, in particular, to mimic the structural role of gluten.
The most used fibers are carob, xanthan gum, and guar cellulose and its derivatives [76,77]. Protein-free
pasta has a low content of fiber because a specific rout of production is used for its production that
does not need the addition of specific ingredients. Currently, protein-free products have been further
enriched with fibers. Fibers content have been increased significantly in all products, including pasta
and baked products, not only for a technological reason but also for the well-known metabolic role of
fibers, in particular regarding gut microbiota composition and metabolism.
Comparing the nutritional facts labels of protein-free products available about 10 years ago and
the current ones, a relevant increase in fibers content emerges. The average content of fiber in bread
increased from 4.2 to 10.8 g per 100 g, from 1.5 to 4.8 g per 100 g in pasta, and from 0.8 to 3.3 g per 100
g in biscuits and cakes. Instead, the fiber content in protein-free flour is quite the same.
Table 4 reports the fiber content of the main categories of protein-free products; the data resulted
from the five better-known brands of protein-free products. Not surprisingly, the fiber content in
protein-free products is higher than that of regular products. For example, the average content of fiber
for regular pasta is 2.7 g/100 g versus 4.8 g/100 g of protein-free pasta. The average content of fiber in
regular bread is 2.7 g/100 g versus 10.8 g/100 g of protein-free bread that is even higher than that of
whole-grain bread, 6.5 g/100 g (fiber content of regular products comes from the National Institute for
Food and Nutrition database) [78]. It is quite interesting to observe also that the types of fiber currently
used seem to be more natural with respect to the past (Table 4).
Achieving higher fiber intake remains a concern in the renal diet because of increased potassium
and phosphorus levels. Foods added in fiber or supplements may be a useful option for the high
energetic amount and the reduced content in electrolytes. Remarkably, fiber supplementation in
CKD patients was shown to lower plasma p-cresol by 20% to 37% (in participants with elevated
compliance) [6].
A low protein diet with an increased dietary fiber content might add additional benefit in the rate
of progression of CKD, but the causal relationship in preserving kidney function could be difficult to
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establish between higher dietary fiber and the low protein diet. Whether dietary fiber per se or the
other nutrients that are present in the foods that are high in fiber decrease systemic inflammation is
still an open question. Fruits and vegetables contain vitamins and antioxidants, making these foods
necessary for a healthy diet, and natural sources are to be preferred [79]. Bioavailability of phosphorus
in fruits, vegetables, and whole grains is lower when compared to processed food [80]. To reach
enough dietary fiber and to ensure a low potassium content in the diet for patients with advanced
CKD, vegetables should be cooked by boiling in water before ingestion and fruit should be properly
selected [61,81].
Table 4. The fiber content of the main categories of protein-free foods made by five of the most known
brands of protein-free products. The data refer to 100 g of edible product.
Fiber Content (g/100 g) Type of Fibers
Median (IQ) Min–Max
Bread 12.5 (7.5–13) 5.0–13 Cellulose, psyllium, apple extract, deglutinated
wheat fiberBread substitutes 7.4 (6.7–9.0) 4.0–15
Pasta 4.8 (2.8–5.7) 3.0–7.3 Cellulose, inulin
Biscuits and cakes 3.2 (2.0–3.6) 0.5–8.5 Bamboo fiber, pectin,
Flour (for bread) 3.0 (2.8–4.0) 2.7–5.4 Cellulose, psyllium, apple extract, deglutinatedwheat fiber
Restoring fiber intake after a prolonged period of dietary deficiency represents a significant
challenge, not simply educational but also physiological. “Addition of” or “changes in” fiber intake
leads to bloating, abdominal cramps, and increased flatulence. Furthermore, delayed gastric emptying
and digestion, from soluble and viscous fibers, may aggravate symptoms of dyspepsia. These unwanted
symptoms are associated with many gastrointestinal and functional disorders and may affect adherence
to adopt a high fiber diet [28].
Considering the association of fiber and hard outcomes, high dietary total fiber intake has been
linked with better kidney function and a lower risk of inflammation and mortality in CKD patients of
North America [53] and Northern Europe [82].
6. Fiber in Dialysis
The effects of fiber intake in dialysis patients have been assessed and reviewed by Sirich and
collaborators [83,84]. In dialysis patients, an increase in dietary protein intake is suggested by current
guidelines, between 1.1 g/kg/day [85] and 1.2 g/kg/day [16]. This may lead to increased production
of protein-derived uremic toxins produced by the colon microbiota, which may be responsible for
symptoms and increased cardiovascular morbidity. This effect may be offset by an increased fiber intake,
as demonstrated by a study in hemodialysis patients, who showed significantly reduced plasma levels of
indoxyl sulfate after an increase in dietary fiber in the form of high amylose corn starch for 6 weeks [83].
Another group [86] previously showed that increasing dietary fiber (oligofructose-enriched inulin
for 4 weeks) reduced the production of p-cresol in hemodialysis patients. The proposed protective
mechanism of fiber is related to increased delivery of SCFAs to the colon, providing energy and
allowing microbes to incorporate dietary protein for growth rather than producing uremic toxins from
protein breakdown [87].
Among nondiabetic peritoneal dialysis patients, fiber intake was inversely associated with
all-cause mortality, with a 13% reduction of mortality for each 1 g/day of increased fiber intake [88].
Moreover, in another recent prospective cohort study of 219 prevalent hemodialysis patients, dietary
fiber intake was associated with less inflammation, less myocardial hypertrophy, injury, and a reduced
risk of major adverse cardiovascular events [89].
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Currently, there is no indication on the ideal fiber intake for hemodialysis patient, but the estimated
intake is only 11–12 g/day compared to the suggested intake for the general population of 25 g/day for
women and 38 g/day for men [84].
7. Conclusions
Although no clear-cut evidence so far can prove the direct effect of dietary fiber in retarding
the progression of CKD, and the possible adverse effects of a fiber-rich diet in end-stage CKD, such
as dyspepsia, may offset its potential benefits, a proper amount of fiber could be recommended
not only in the general population but also in people affected by CKD, to maintain an adequate
composition and metabolism of gut microbiota and to reduce the risks connected with obesity, diabetes,
and dyslipidemia. Fibers are a diversified family of compounds, classified considering viscosity,
fermentability, and bulking effect in the colon, which is related to aqueous solubility. The main sources
of dietary fiber are the cereal grains, starchy endosperm, fruits and vegetable cell walls, green banana,
psyllium, legumes, guar gum, beetroot, rice endosperm, chicory root, Jerusalem artichoke, onion,
polymers derived by hydrolysis from polysaccharides, red algae, and fungi. Dietary fiber can modulate
the gut microbiota metabolism of CKD patients, reducing the bacterial generation of uremic toxins and
potentially improving CKD progression and, even in dialysis patients, improving uremic symptoms
and comorbidities. More clinical studies need to be conducted to assess the potential multifactorial
benefits of a natural diet rich in fiber in CKD and define the impact of quality and quantity composition
in different kinds of fiber.
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